Trademark: 87406461
Word
RYVESTA
Status
Dead
Status Code
606
Status Date
Monday, February 20, 2023
Serial Number
87406461
Mark Type
4000
Filing Date
Tuesday, April 11, 2017
Published for Opposition
Tuesday, May 24, 2022
Abandoned Date
Monday, February 20, 2023

Trademark Owner History
Novartis AG - Owner At Publication

Classifications
5 Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of kidney diseases; Pharmaceutical preparations for the prevention and treatment of diabetes; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical preparations for the prevention and treatment of allergies; Pharmaceutical products for the prevention and treatment of bone diseases; Pharmaceutical products for the prevention and treatment of respiratory diseases and asthma
The wording "RYVESTA" has no meaning in a foreign language.

Trademark Events
Feb 21, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 20, 2023
Abandonment - No Use Statement Filed
Jul 19, 2022
Noa E-Mailed - Sou Required From Applicant
May 24, 2022
Official Gazette Publication Confirmation E-Mailed
May 24, 2022
Published For Opposition
May 4, 2022
Notification Of Notice Of Publication E-Mailed
Apr 21, 2022
Law Office Publication Review Completed
Apr 15, 2022
Approved For Pub - Principal Register
Feb 3, 2021
Suspension Checked - To Attorney For Action
Jun 26, 2020
Report Completed Suspension Check Case Still Suspended
Dec 13, 2019
Report Completed Suspension Check Case Still Suspended
Dec 13, 2019
Assigned To Lie
Oct 30, 2019
Assigned To Examiner
May 13, 2019
Report Completed Suspension Check Case Still Suspended
Nov 13, 2018
Report Completed Suspension Check Case Still Suspended
May 10, 2018
Report Completed Suspension Check Case Still Suspended
Oct 27, 2017
Report Completed Suspension Check Case Still Suspended
Apr 27, 2017
Notification Of Letter Of Suspension E-Mailed
Apr 27, 2017
Letter Of Suspension E-Mailed
Apr 27, 2017
Suspension Letter Written
Apr 27, 2017
Assigned To Examiner
Apr 18, 2017
New Application Office Supplied Data Entered
Apr 14, 2017
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24